(QQQI) NEOS Nasdaq 100 High Income - Ratings and Ratios

Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • ISIN: US78433H6751 • Derivative Income

QQQI: Stocks, Call Options

Meet the NEOS Nasdaq 100 High Income ETF (QQQI), an actively-managed exchange-traded fund listed on the NASDAQ. This fund is designed for investors seeking income through a unique strategy that combines equity exposure with options trading.

QQQI invests in stocks from the Nasdaq-100 Index, a benchmark known for its tech giants and growth-oriented companies. But heres the twist: the fund also employs a call options strategy. By writing (selling) call options on the Nasdaq-100 Index, QQQI aims to generate additional income from option premiums. This approach can potentially enhance yields, especially in markets with low volatility or when the underlying index is range-bound.

Under normal market conditions, at least 80% of the funds net assets (plus any borrowings for investment purposes) are allocated to securities or derivatives linked to the Nasdaq-100 Index. This ensures the fund stays aligned with its reference index while pursuing its income objectives.

With approximately $951 million in assets under management, QQQI falls under the Derivative Income ETF category. This classification reflects its use of derivatives to generate income, which sets it apart from traditional equity or fixed-income ETFs. The funds structure allows it to offer a higher distribution yield compared to what you might earn from simply holding the stocks in the Nasdaq-100 Index.

For investors and fund managers, its important to understand that QQQIs options strategy introduces a trade-off: while it can provide higher income, it may also cap potential upside during strong market rallies. The funds performance will depend on the interplay between the Nasdaq-100 Indexs returns and the income generated from option premiums.

If youre considering QQQI, make sure you understand the underlying index, the mechanics of the call options strategy, and how they align with your investment goals. Its not just about chasing yield; its about evaluating whether this specific combination of growth and income fits within your broader portfolio and risk tolerance.

Additional Sources for QQQI ETF

QQQI ETF Overview

Market Cap in USD 1,077m
Category Derivative Income
TER 0.68%
IPO / Inception 2024-01-29

QQQI ETF Ratings

Growth Rating 35.9
Fundamental -
Dividend Rating 48.4
Rel. Strength 0.91
Analysts -
Fair Price Momentum 42.02 USD
Fair Price DCF -

QQQI Dividends

Dividend Yield 12m 15.84%
Yield on Cost 5y 17.44%
Annual Growth 5y -47.93%
Payout Consistency 100.0%

QQQI Growth Ratios

Growth Correlation 3m -86.4%
Growth Correlation 12m 69.9%
Growth Correlation 5y 80.6%
CAGR 5y 6.03%
CAGR/Max DD 5y 0.30
Sharpe Ratio 12m 1.52
Alpha -0.32
Beta 1.028
Volatility 46.00%
Current Volume 476.4k
Average Volume 20d 835.2k
What is the price of QQQI stocks?
As of April 19, 2025, the stock is trading at USD 45.31 with a total of 476,407 shares traded.
Over the past week, the price has changed by -0.09%, over one month by -6.97%, over three months by -12.06% and over the past year by +5.88%.
Is NEOS Nasdaq 100 High Income a good stock to buy?
Partly, yes. Based on ValueRay Analyses, NEOS Nasdaq 100 High Income (NASDAQ:QQQI) is currently (April 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 35.89 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of QQQI as of April 2025 is 42.02. This means that QQQI is currently overvalued and has a potential downside of -7.26%.
Is QQQI a buy, sell or hold?
NEOS Nasdaq 100 High Income has no consensus analysts rating.
What are the forecast for QQQI stock price target?
According to ValueRays Forecast Model, QQQI NEOS Nasdaq 100 High Income will be worth about 46.7 in April 2026. The stock is currently trading at 45.31. This means that the stock has a potential upside of +3.05%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 46.7 3%